Market News & Trends
Genisphere Pursues Neurotherapeutics Under Collaboration Agreement With Inserm
Genisphere LLC has signed a collaborative research agreement with The Institut national de la santé et de la recherche médicale (Inserm, The French National Institute…
Cognition Therapeutics Receives Fast Track Designation for First-in-Class Alzheimer’s Candidate
Cognition Therapeutics, Inc., a clinical-stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive disorders, recently…
Vetter to Expand its Secondary Packaging Service Capacity to Meet Rising Demands
Vetter, a global leader in prefilled drug delivery systems and an expert in complex packaging projects, recently announced a major expansion of its secondary packaging capacities…
Arcturus Therapeutics Announces Strategic Collaboration With J&J Innovation to Discover & Develop RNA Medicines
Arcturus Therapeutics, Inc., a leading RNA medicines company, recently announced today it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals,…
White Paper: Establishing cGMP Manufacturing Capability for Phase 1 Sterile, Dispersed, Injectable Dosage Forms
As a product transitions from pre-clinical development to a clinical development phase, the manufacturing process takes on a much greater role in the overall success…
Cellectar Biosciences & Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates
Cellectar Biosciences, Inc., an oncology-focused, clinical-stage biotechnology company, together with leading French pharmaceutical company Pierre Fabre, recently announced the extension of their ongoing collaboration to…
Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, recently shared the results of a study highlighting the benefits…
pSivida & Nicox Enter Strategic Collaboration Agreement to Develop Sustained Release Drug
pSivida Corp., a leader in the development of sustained release drug products and technologies, and Nicox S.A., the international ophthalmic company, recently announced their entry…
Mustang Bio Announces $12.8-Million Grant to Fund Clinical Trial of CAR T Therapy
Mustang Bio, Inc., a Fortress Biotech, Inc. company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (CAR…
Piramal Pharma Solutions Announces Large-Scale Expansion of API Manufacturing Facilities
Piramal Pharma Solutions Announces Large-Scale Expansion of API Manufacturing Facilities Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), recently announced investments…
NanOlogy Announces First Patient Enrolled in Phase 2 Clinical Trial of NanoPac
NanOlogy LLC , a clinical-stage pharmaceutical development company, recently announced enrollment of the first patient in a Phase 2 clinical trial of intraperitoneally (IP) administered…
AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis & Toxicology Risk Assessment
AMRI, a global contract research, development and manufacturing organization that partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life,…
Cambrex Invests in Generic API Development & Manufacturing Capabilities at its Milan Site
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently announced that it has made a number of investments,…
Aptar Pharma Showcase its Premium Injectables Portfolio
Aptar Pharma, a leading drug delivery systems provider, will showcase the latest developments in its Premium injectables portfolio when it exhibits at Parenteral Drug Association’s…
eFFECTOR Initiates Dosing in Phase II Combination Trial
eFFECTOR Therapeutics, Inc. recently announced it has initiated dosing in a Phase 2 clinical study of eFT508 in combination with avelumab in microsatellite stable colorectal…
Recursion Pharmaceuticals Raises $60 Million to Industrialize Drug Discovery Using Artificial Intelligence
Recursion Pharmaceuticals, a biotechnology company that combines innovative biological science with artificial intelligence to discover new therapeutics at scale, is announcing its $60-million Series B…
OSE Immunotherapeutics Signs License Option Agreement
OSE Immunotherapeutics SA recently announced it has entered into an agreement with Inserm Transfert, on behalf of Inserm, a French public organization dedicated to human…
NANOBIOTIX Plans to Conduct First Clinical Trial
Nanobiotix recently announced its intention to start a new trial in the company's immuno-oncology (IO) program. The trial is aimed at expanding the potential of…
AIT Therapeutics Granted Orphan Drug Designation
AIT Therapeutics Inc. recently announced the US FDA has granted orphan drug designation to the company for its novel NO formulation for the treatment of…
Intra-Cellular Therapies Announces Enrollment of Clinical Trial
Intra-Cellular Therapies, Inc. recently announced the company has commenced enrollment in the ITI-214-105 Phase 1/2 clinical trial in patients with Parkinson’s disease (PD). “ITI-214 is…
